Burden of Diabetes, Untreated Diabetes Increased From 1990 to 2022
By Elana Gotkine HealthDay Reporter
FRIDAY, Nov. 15, 2024 -- The global burden of diabetes and untreated diabetes increased from 1990 to 2022, according to a study published online Nov. 13 in The Lancet.
Bin Zhou, Ph.D., from Imperial College London, and colleagues used data from 1,108 population-representative studies with 141 million participants aged 18 years and older to examine trends in diabetes prevalence and treatment from 1990 to 2022.
The researchers found that an estimated 828 million adults had diabetes in 2022, representing an increase of 630 million from 1990. The age-standardized prevalence of diabetes increased from 1990 to 2022 in 131 and 155 countries for women and men, respectively, with a posterior probability of more than 0.80. Low-income and middle-income countries in Southeast Asia, South Asia, the Middle East and North Africa, and Latin America and the Caribbean had the largest increases. In 2022, 445 million adults (59 percent) aged 30 years or older with diabetes did not receive treatment, a 3.5-fold increase from 1990. Diabetes treatment coverage increased from 1990 to 2018 in 118 and 98 countries for women and men, respectively, with a posterior probability of more than 0.80. Some countries from Central and Western Europe and Latin America (Mexico, Colombia, Chile, and Costa Rica), Canada, South Korea, Russia, Seychelles, and Jordan had the largest improvement in treatment, while most countries in sub-Saharan Africa; the Caribbean; Pacific island nations; and South, Southeast, and Central Asia had no increase in treatment coverage.
"The current variations in treatment were largely related to the extent of diabetes underdiagnosis, which means that improving case detection is a prerequisite to increasing treatment coverage," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-16 06:00
Read more
- There's a 'Sweet Spot' for Daily Sugar Intake & Heart Health
- Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia
- Sleep-Disordered Breathing Linked to Larger Hippocampal Volume
- Check Your Pantry, Lay's Classic Potato Chips Recalled Due to Milk Allergy Risk
- Aquestive Therapeutics Announces Positive FDA Feedback and Reaffirms NDA Submission Guidance for Anaphylm (epinephrine) Sublingual Film
- Infertility Without Treatment Linked to Autoimmune Rheumatic Disease After Childbirth
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions